Siregar, G., Paramesh, R., Kumawat, R., D, P., & HA, S. (2021). A prospective, interventional clinical study to evaluate the safety and efficacy of Liv.52 DS in the management of non-alcoholic fatty liver disease. European Journal of Clinical and Experimental Medicine, 19(2), 129–136. https://doi.org/10.15584/ejcem.2021.2.3